Codexis, a biocatalyst research company, signs “multimillion” dollar deal with Merck
Codexis, a biocatalyst research company based in Redwood City, Ca., has signed a significant licensing deal with Merck & Co.
See the statement here. The terms weren’t disclosed, but the company tells VentureWire it is in the multimillions of dollars (sub required).
Next Story: Battery Ventures buys Quovadx for $136.7M
Previous Story: Samplify, an IP compression technology, raises $6.5M
